The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vroon, A.
Right arrow Articles by Heijnen, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vroon, A.
Right arrow Articles by Heijnen, C. J.
The Journal of Immunology, 2005, 174: 4400-4406.
Copyright © 2005 by The American Association of Immunologists

G Protein-Coupled Receptor Kinase 2 in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Anne Vroon*, Annemieke Kavelaars*, Volker Limmroth{dagger}, Maria Stella Lombardi*, Marion U. Goebel{ddagger}, Anne-Marie Van Dam§, Marc G. Caron, Manfred Schedlowski|| and Cobi J. Heijnen1,*

* Laboratory for Psychoneuroimmunology, University Medical Center Utrecht, Utrecht, The Netherlands; Departments of {dagger} Neurology and {ddagger} Medical Psychology, Medical Faculty, University of Essen, Essen, Germany; § Department of Medical Pharmacology, Research Institute Neurosciences, VU University Medical Center, Amsterdam, The Netherlands; Howard Hughes Medical Institute Laboratories, Departments of Cell Biology and Medicine, Duke University Medical Center, Durham, NC 27710; and || Department of Psychology and Behavioral Immunobiology, Swiss Federal Institute of Technology, Zürich, Switzerland

Many modulators of inflammation, including chemokines, neuropeptides, and neurotransmitters signal via G protein-coupled receptors (GPCR). GPCR kinases (GRK) can phosphorylate agonist-activated GPCR thereby promoting receptor desensitization. Here we describe that in leukocytes from patients with active relapsing-remitting multiple sclerosis (MS) or with secondary progressive MS, GRK2 levels are significantly reduced. Unexpectedly, cells from patients during remission express even lower levels of GRK2. The level of GRK2 in leukocytes of patients after stroke, a neurological disorder with paralysis but without an autoimmune component, was similar to GRK2 levels in cells from healthy individuals. In addition, we demonstrate that the course of recombinant myelin oligodendrocyte glycoprotein (1–125)-induced experimental autoimmune encephalomyelitis (EAE), an animal model for MS, is markedly different in GRK2+/– mice that express 50% of the GRK2 protein in comparison with wild-type mice. Onset of EAE was significantly advanced by 5 days in GRK2+/– mice. The earlier onset of EAE was associated with increased early infiltration of the CNS by T cells and macrophages. Although disease scores in the first phase of EAE were similar in both groups, GRK2+/– animals did not develop relapses, whereas wild-type animals did. The absence of relapses in GRK2+/– mice was associated with a marked reduction in inflammatory infiltrates in the CNS. Recombinant myelin oligodendrocyte glycoprotein-induced T cell proliferation and cytokine production were normal in GRK2+/– animals. We conclude that down-regulation of GRK2 expression may have important consequences for the onset and progression of MS.


Related articles in The JI:

IN THIS ISSUE

The JI 2005 174: 3837-3838. [Full Text]  



This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. H. A. Nijboer, A. Kavelaars, A. Vroon, F. Groenendaal, F. van Bel, and C. J. Heijnen
Low Endogenous G-Protein-Coupled Receptor Kinase 2 Sensitizes the Immature Brain to Hypoxia-Ischemia-Induced Gray and White Matter Damage
J. Neurosci., March 26, 2008; 28(13): 3324 - 3332.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Lattin, D. A. Zidar, K. Schroder, S. Kellie, D. A. Hume, and M. J. Sweet
G-protein-coupled receptor expression, function, and signaling in macrophages
J. Leukoc. Biol., July 1, 2007; 82(1): 16 - 32.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
N. Eijkelkamp, C. J Heijnen, A. Lucas, R. T Premont, S. Elsenbruch, M. Schedlowski, and A. Kavelaars
G protein-coupled receptor kinase 6 controls chronicity and severity of dextran sodium sulphate-induced colitis in mice
Gut, June 1, 2007; 56(6): 847 - 854.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
C Heesen, D C Mohr, I Huitinga, F T. Bergh, J Gaab, C Otte, and S M Gold
Stress regulation in multiple sclerosis-current issues and concepts
Multiple Sclerosis, March 1, 2007; 13(2): 143 - 148.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Vroon, C. J. Heijnen, and A. Kavelaars
GRKs and arrestins: regulators of migration and inflammation
J. Leukoc. Biol., December 1, 2006; 80(6): 1214 - 1221.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. del Rey, V. Renigunta, A. H. Dalpke, J. Leipziger, J. E. Matos, B. Robaye, M. Zuzarte, A. Kavelaars, and P. J. Hanley
Knock-out Mice Reveal the Contributions of P2Y and P2X Receptors to Nucleotide-induced Ca2+ Signaling in Macrophages
J. Biol. Chem., November 17, 2006; 281(46): 35147 - 35155.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. C. Jimenez-Sainz, C. Murga, A. Kavelaars, M. Jurado-Pueyo, B. F. Krakstad, C. J. Heijnen, F. Mayor Jr., and A. M. Aragay
G Protein-coupled Receptor Kinase 2 Negatively Regulates Chemokine Signaling at a Level Downstream from G Protein Subunits
Mol. Biol. Cell, January 1, 2006; 17(1): 25 - 31.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.